Cargando…

Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration

Per- and polyfluoroalkyl substances (PFAS) are endocrine-disrupting chemicals that may affect breastfeeding duration. We examined associations between maternal PFAS concentrations during pregnancy and breastfeeding cessation. We investigated potential effect modification by parity status. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedman, Chloe, Dabelea, Dana, Keil, Alexander P., Adgate, John L., Glueck, Deborah H., Calafat, Antonia M., Starling, Anne P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402953/
https://www.ncbi.nlm.nih.gov/pubmed/37545807
http://dx.doi.org/10.1097/EE9.0000000000000260
_version_ 1785084953804931072
author Friedman, Chloe
Dabelea, Dana
Keil, Alexander P.
Adgate, John L.
Glueck, Deborah H.
Calafat, Antonia M.
Starling, Anne P.
author_facet Friedman, Chloe
Dabelea, Dana
Keil, Alexander P.
Adgate, John L.
Glueck, Deborah H.
Calafat, Antonia M.
Starling, Anne P.
author_sort Friedman, Chloe
collection PubMed
description Per- and polyfluoroalkyl substances (PFAS) are endocrine-disrupting chemicals that may affect breastfeeding duration. We examined associations between maternal PFAS concentrations during pregnancy and breastfeeding cessation. We investigated potential effect modification by parity status. METHODS: Among 555 women enrolled in the Healthy Start study (2009–2014), we quantified maternal serum concentrations of 5 PFAS during mid- to late-pregnancy (mean 27 weeks of gestation). Participants self-reported their breastfeeding practices through 18–24 months postnatally. Among all participants and stratified by parity, we estimated associations between maternal PFAS concentrations and breastfeeding discontinuation by 3 and 6 months, using Poisson regression, and breastfeeding duration, using Cox regression. RESULTS: Median PFAS concentrations were similar to those in the general US population. Associations between PFAS and breastfeeding duration differed by parity status. After adjusting for covariates, among primiparous women, associations between PFAS and breastfeeding cessation by 3 and 6 months were generally null, with some inverse associations. Among multiparous women, there were positive associations between perfluorohexane sulfonate, perfluorooctane sulfonate, perfluorooctanoate (PFOA), and perfluorononanoate and breastfeeding cessation by 3 and 6 months. For example, per ln-ng/mL increase in PFOA, the risk ratio for breastfeeding discontinuation by 6 months was 1.45 (95% confidence interval, 1.18, 1.78). Hazard ratios reflected similar patterns between PFAS and breastfeeding duration. CONCLUSIONS: Among primiparous women, we did not find evidence for associations between PFAS concentrations and breastfeeding duration. In contrast, among multiparous women, PFAS serum concentrations were generally inversely associated with breastfeeding duration, though estimates may be biased due to confounding by unmeasured previous breastfeeding.
format Online
Article
Text
id pubmed-10402953
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104029532023-08-05 Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration Friedman, Chloe Dabelea, Dana Keil, Alexander P. Adgate, John L. Glueck, Deborah H. Calafat, Antonia M. Starling, Anne P. Environ Epidemiol Original Research Article Per- and polyfluoroalkyl substances (PFAS) are endocrine-disrupting chemicals that may affect breastfeeding duration. We examined associations between maternal PFAS concentrations during pregnancy and breastfeeding cessation. We investigated potential effect modification by parity status. METHODS: Among 555 women enrolled in the Healthy Start study (2009–2014), we quantified maternal serum concentrations of 5 PFAS during mid- to late-pregnancy (mean 27 weeks of gestation). Participants self-reported their breastfeeding practices through 18–24 months postnatally. Among all participants and stratified by parity, we estimated associations between maternal PFAS concentrations and breastfeeding discontinuation by 3 and 6 months, using Poisson regression, and breastfeeding duration, using Cox regression. RESULTS: Median PFAS concentrations were similar to those in the general US population. Associations between PFAS and breastfeeding duration differed by parity status. After adjusting for covariates, among primiparous women, associations between PFAS and breastfeeding cessation by 3 and 6 months were generally null, with some inverse associations. Among multiparous women, there were positive associations between perfluorohexane sulfonate, perfluorooctane sulfonate, perfluorooctanoate (PFOA), and perfluorononanoate and breastfeeding cessation by 3 and 6 months. For example, per ln-ng/mL increase in PFOA, the risk ratio for breastfeeding discontinuation by 6 months was 1.45 (95% confidence interval, 1.18, 1.78). Hazard ratios reflected similar patterns between PFAS and breastfeeding duration. CONCLUSIONS: Among primiparous women, we did not find evidence for associations between PFAS concentrations and breastfeeding duration. In contrast, among multiparous women, PFAS serum concentrations were generally inversely associated with breastfeeding duration, though estimates may be biased due to confounding by unmeasured previous breastfeeding. Lippincott Williams & Wilkins 2023-06-16 /pmc/articles/PMC10402953/ /pubmed/37545807 http://dx.doi.org/10.1097/EE9.0000000000000260 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The Environmental Epidemiology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Research Article
Friedman, Chloe
Dabelea, Dana
Keil, Alexander P.
Adgate, John L.
Glueck, Deborah H.
Calafat, Antonia M.
Starling, Anne P.
Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration
title Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration
title_full Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration
title_fullStr Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration
title_full_unstemmed Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration
title_short Maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration
title_sort maternal serum per- and polyfluoroalkyl substances during pregnancy and breastfeeding duration
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402953/
https://www.ncbi.nlm.nih.gov/pubmed/37545807
http://dx.doi.org/10.1097/EE9.0000000000000260
work_keys_str_mv AT friedmanchloe maternalserumperandpolyfluoroalkylsubstancesduringpregnancyandbreastfeedingduration
AT dabeleadana maternalserumperandpolyfluoroalkylsubstancesduringpregnancyandbreastfeedingduration
AT keilalexanderp maternalserumperandpolyfluoroalkylsubstancesduringpregnancyandbreastfeedingduration
AT adgatejohnl maternalserumperandpolyfluoroalkylsubstancesduringpregnancyandbreastfeedingduration
AT glueckdeborahh maternalserumperandpolyfluoroalkylsubstancesduringpregnancyandbreastfeedingduration
AT calafatantoniam maternalserumperandpolyfluoroalkylsubstancesduringpregnancyandbreastfeedingduration
AT starlingannep maternalserumperandpolyfluoroalkylsubstancesduringpregnancyandbreastfeedingduration